Jordan Berlin, M.D, is a medical oncologist who specializes in gastrointestinal cancers and investigational drug development (Phase I). In his roles as the Associate Director for Clinical Research and Director of Phase I Research at the Vanderbilt-Ingram Cancer Center, Dr. Berlin serves to coordinate clinical and translational efforts across the cancer center from the research programs to the phase I program as well as from within the VICC research programs. He is responsible for advancing preclinical data and investigational drugs to investigator-initiated trials and clinical evaluation. Dr. Berlin has extensive experience designing investigator-initiated and cooperative group trials as well as experience advising the pharmaceutical industry on trial design and development. Dr. Berlin is the PI of the VICC National Clinical Trials Network Lead Academic Participating Site Grant and the VICC PI of the VIKTriY multi-site UM1 grant led overall by Pat LoRusso at Yale Cancer Center. Additionally, as the immediate-past Medical Director of the Clinical Trials Office (CTO), he mentors several junior investigators in phase I and GI malignancies and continues to mentor Vicki Keedy, M.D. in her role as current Medical Director of the CTO.